| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 116,420 | 101,396 | 84,403 | 105,887 | | Cost of Revenue | 79,804 | 75,982 | 66,129 | 84,061 | | | Gross Profit | 36,616 | 25,414 | 18,274 | 21,826 | | | Operating Expenses | | Research Development | 4,222 | 4,712 | 4,821 | 5,968 | | Selling General and Administrative | 21,174 | 22,946 | 22,342 | 28,023 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,209 | 1,212 | 1,211 | 943 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,011 | (3,456) | (10,100) | (13,108) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (648) | 237 | 879 | 2,678 | | Earnings Before Interest And Taxes | 9,363 | (3,219) | (9,221) | (10,430) | | Interest Expense | 537 | 637 | 670 | 2,392 | | Income Before Tax | 8,826 | (3,856) | (9,891) | (12,822) | | Income Tax Expense | 768 | (1,272) | (2,107) | (3,597) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,058 | (2,584) | (7,784) | (9,225) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,058 | (2,584) | (7,784) | (9,225) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,058 | ($2,584) | ($7,784) | ($9,225) |
|
0.02% Nasdaq 0.00%
Income Statement
